Bruker AXS Announces SMART BREEZE(TM), an Affordable and Exceptionally Easy-to-Use X-Ray Crystallography System for Automated Mo
12 September 2005 - 9:00PM
Business Wire
Bruker AXS Inc. today announces the launch of SMART BREEZE(TM), a
compact and affordable X-ray crystallography system, which features
Bruker AXS' latest addition to its award-winning X-ray detectors,
the air-cooled SMART BREEZE 4K CCD detector, as well as a compact
goniometer and X-ray generator. The SMART BREEZE system features
the ground-breaking new AutoStructure(TM) software for fully
automatic 3D structure determination of organic and coordination
molecules from X-ray data. The SMART BREEZE's advanced CCD
technology allows it to be air-cooled for low maintenance while
offering a very high level of data quality, superior to most
conventional water-cooled detectors. This novel system with its
intuitive and automated software for structure determination is
ideal for synthetic chemistry research groups, as well as for
chemistry teaching facilities. Dr. Michael Ruf, Director of
Chemical Crystallography Software at Bruker AXS, stated: "X-ray
crystallography has never been easier. After having defined the
high-performance end of the chemical crystallography market for
many years with cutting-edge hardware and software technology, we
are now very excited to be able to offer a lower-cost system with
truly automated, robust structure determination software. The
innovative SMART BREEZE system finally opens the door to
crystallographic structure determination for non-experts. We expect
that easy and fast access to unambiguous structural confirmation of
new compounds will have a rather significant impact on the world of
synthetic chemistry." About Bruker Biosciences (NASDAQ: BRKR)
Bruker BioSciences Corporation, headquartered in Billerica,
Massachusetts, is the publicly traded parent company of Bruker AXS
Inc. and Bruker Daltonics Inc. Bruker AXS is a leading worldwide
developer and provider of advanced X-ray systems which provide
solutions for molecular and elemental analysis by X-ray
crystallography, X-ray diffraction and X-ray fluorescence. Its
integrated systems, which have particular application in the
life-science and materials-science fields, provide customers with
high throughput capabilities to determine the 3D structure of
specific molecules, such as proteins, and to characterize and
determine the composition of materials. Bruker Daltonics is a
leading provider of innovative life science tools based on mass
spectrometry. Please visit www.bruker-axs.com Cautionary Statement
Any statements contained in this press release with respect to
Bruker AXS or Bruker BioSciences or their businesses that do not
describe historical facts may constitute forward-looking statements
as that term is defined in the Private Securities Litigation Reform
Act of 1995. Any forward-looking statements contained herein are
based on current expectations, but are subject to a number of risks
and uncertainties. The factors that could cause actual future
results to differ materially from current expectations include, but
are not limited to, risks and uncertainties relating to the
Company's reorganization strategies, integration risks, failure of
conditions, technological approaches, product development, market
acceptance, cost and pricing of the Company's products, changes in
governmental regulations, capital spending and government funding
policies, FDA and other regulatory approvals to the extent
applicable, competition, the intellectual property of others,
patent protection and litigation. These and other factors are
identified and described in more detail in our filings with the
SEC, including, without limitation, our respective annual reports
on Form 10-K for the year ended December 31, 2004, our most recent
quarterly reports on Form 10-Q, our current reports on Form 8-K and
the joint proxy statement/prospectus filed in connection with the
merger. We disclaim any intent or obligation to update these
forward-looking statements.
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024